Development of the Antileishmanial Vaccine
- PMID: 34914062
- DOI: 10.1007/978-1-0716-1884-4_23
Development of the Antileishmanial Vaccine
Abstract
Search for an efficacious antileishmanial vaccine has led to clinical trials of numerous vaccine candidates in the past few decades. As no promising candidate has emerged from these studies, novel vaccine modalities and vaccine assessment techniques are still emerging for antileishmanial vaccine development. Briefly, this chapter discusses: (a) history and timeline of antileishmanial vaccine development; (b) techniques utilized for developing whole-parasite and subunit-based antileishmanial vaccine formulations, and (c) immunogenicity and post-challenge protective efficacy assessment of vaccine candidates.
Keywords: Antileishmanial vaccine; Electroporation; Flow cytometry; Immunogenicity; Mass spectrometry; Ni-NTA affinity chromatography; Parasite load; T-helper response.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Killick-Kendrick R (1990) The life-cycle of Leishmania in the sandfly with special reference to the form infective to the vertebrate host. Ann Parasitol Hum Comp 65:37–42 - PubMed
-
- Guevara P, Pinto-Santíni D, Rojas A, Crisante G, Añez N, Ramirez JL (2001) Green fluorescent protein-tagged Leishmania in phlebotomine sand flies. J Med Entomol 38:39–43 - PubMed
-
- World Health Organization (2020) Leishmaniasis. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis . Accessed 10 Jun 2020
-
- Khamesipour A, Dowlati Y, Asilian A, Hashemi-Fesharki R, Javadi A, Noazin S et al (2005) Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine 23:3642–3648 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous